Research & Publications
Georgia Charkoftaki received her pharmacy degree from the University of Athens, Greece, where she also earned a MSC in drug delivery and a PhD in biopharmaceutics-pharmacokinetics. In August 2013 she moved to the University Colorado Denver to start a postdoc in clinical and translational science, focusing on kidney related diseases. Charkoftaki studied the pharmacokinetics of cyclophosphamide in patients undergoing dialysis and how Vitamin D affects drug metabolism in the kidneys, among other projects. At Yale, she has focused on studying the underlying pathology/mechanisms of the aldehyde dehydrogenases in various diseases, including cancer and neurodevelopmental disorders. She is using multi-omics approaches and she is an expert in studying the metabolome (metabolomics), lipidome (lipidomics), and utilizing tissue imaging mass spectrometry (IMS) with a special focus on MALDI.
Honors & Recognition
|Elected Secretary||Imaging Mass Spectrometry Society||2020|